Market Overview

UPDATE: Jefferies & Company Upgrades Molina Healthcare to Hold, Raises PT

Related MOH
Humana Investors Disappointed With Results Of Medicare Star Quality Ratings
Regardless Of Election Results, Bloomberg And Goldman Sachs Say Buy Stocks Linked To Federal Spending
UnitedHealth Stock Surges Close To Buy Point On Earnings, Guidance (Investor's Business Daily)

In a report published Friday, Jefferies & Company upgraded its rating on Molina Healthcare (NYSE: MOH) from Underperform to Hold, and raised its price target from $19.00 to $24.00.

Jefferies noted, “After speaking with management, we see a high probability that MOH strikes a California pricing deal, similar to HNT's, in the coming weeks. This would reduce downside risk and be well received by the market. Consequently, we are upgrading to Hold ahead of this positive catalyst. We value the benefit to MOH's profitability at $5. Importantly, without this deal, we believe the 2013 consensus is high.”

Molina Healthcare closed on Thursday at $26.41.

Latest Ratings for MOH

Sep 2016Goldman SachsUpgradesSellNeutral
Sep 2016JefferiesMaintainsBuy
Aug 2016BarclaysTerminatesEqual-Weight

View More Analyst Ratings for MOH
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Upgrades Analyst Ratings


Related Articles (MOH)

View Comments and Join the Discussion!